Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Athira Pharma (ATHA)
NASDAQ:ATHA
Athira Pharma (ATHA) Stock Price & Analysis
484 Followers
ATHA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.33 - $4.30
Previous Close$2.11
Volume111.53K
Average Volume (3M)369.67K
Market Cap
$80.87M
Enterprise Value-$92.32M
Total Cash (Recent Filing)$172.95M
Total Debt (Recent Filing)$1.67M
Price to Earnings (P/E)-0.7
Beta0.50
Next Earnings
May 09, 2024EPS Estimate
-$0.8Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.09
Shares Outstanding38,326,652
10 Day Avg. Volume203,156
30 Day Avg. Volume369,667
Standard Deviation0.26
R-Squared0.29
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.61
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.77
Forecast
1Y Price Target
$11.33Price Target Upside436.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Athira Pharma News
Ownership Overview
31.37% Insiders
8.47% Mutual Funds
9.05% Other Institutional Investors
51.11% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ATHA FAQ
What was Athira Pharma’s price range in the past 12 months?
Athira Pharma lowest stock price was $1.33 and its highest was $4.30 in the past 12 months.
What is Athira Pharma’s market cap?
Currently, no data Available
When is Athira Pharma’s upcoming earnings report date?
Athira Pharma’s upcoming earnings report date is May 09, 2024 which is in 20 days.
How were Athira Pharma’s earnings last quarter?
Athira Pharma released its earnings results on Feb 22, 2024. The company reported -$0.71 earnings per share for the quarter, beating the consensus estimate of -$0.838 by $0.128.
Is Athira Pharma overvalued?
According to Wall Street analysts Athira Pharma’s price is currently Undervalued.
Does Athira Pharma pay dividends?
Athira Pharma does not currently pay dividends.
What is Athira Pharma’s EPS estimate?
Athira Pharma’s EPS estimate is -$0.8.
How many shares outstanding does Athira Pharma have?
Athira Pharma has 38,326,653 shares outstanding.
What happened to Athira Pharma’s price movement after its last earnings report?
Athira Pharma reported an EPS of -$0.71 in its last earnings report, beating expectations of -$0.838. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Athira Pharma?
Among the largest hedge funds holding Athira Pharma’s share is Perceptive Advisors LLC. It holds Athira Pharma’s shares valued at 13M.
---
Athira Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.33 (436.97% Upside)
$11.33 (436.97% Upside)
Hedge Fund Trend
Increased
By 605.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 7.3%
Last 30 Days ▼ 7.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.27%
12-Months-Change
Fundamentals
Return on Equity
-64.42%
Trailing 12-Months
Asset Growth
-37.93%
Trailing 12-Months
Company Description
Athira Pharma
Athira Pharma Inc is a bio-technology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.
---
ATHA Stock 12 Months Forecast
Average Price Target
$11.33
▲(436.97% Upside)
Technical Analysis
Best Analysts Covering ATHA
1 Year
1 Year Success Rate
2/13 ratings generated profit
1 Year Average Return
-21.41%
reiterated a buy rating 2 months ago
Copying Graig Suvannavejh's trades and holding each position for 1 Year would result in 15.38% of your transactions generating a profit, with an average return of -21.41% per trade.
---